Simon C. Johnson

6.1k total citations · 1 hit paper
42 papers, 3.5k citations indexed

About

Simon C. Johnson is a scholar working on Molecular Biology, Clinical Biochemistry and Aging. According to data from OpenAlex, Simon C. Johnson has authored 42 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 10 papers in Aging. Recurrent topics in Simon C. Johnson's work include Mitochondrial Function and Pathology (22 papers), Metabolism and Genetic Disorders (10 papers) and Genetics, Aging, and Longevity in Model Organisms (10 papers). Simon C. Johnson is often cited by papers focused on Mitochondrial Function and Pathology (22 papers), Metabolism and Genetic Disorders (10 papers) and Genetics, Aging, and Longevity in Model Organisms (10 papers). Simon C. Johnson collaborates with scholars based in United States, United Kingdom and France. Simon C. Johnson's co-authors include Peter S. Rabinovitch, Matt Kaeberlein, Dao‐Fu Dai, Hazel H. Szeto, Tony Chen, Margaret M. Sedensky, Maya Sangesland, Philip G. Morgan, Madeline Nieves‐Cintrón and Luis F. Santana and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Simon C. Johnson

41 papers receiving 3.5k citations

Hit Papers

mTOR is a key modulator o... 2013 2026 2017 2021 2013 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Simon C. Johnson 2.0k 847 664 349 298 42 3.5k
Kit‐Yi Leung 2.0k 1.0× 954 1.1× 387 0.6× 282 0.8× 106 0.4× 60 4.0k
Nathan Basisty 1.7k 0.8× 1.2k 1.4× 449 0.7× 390 1.1× 197 0.7× 54 3.1k
Dao‐Fu Dai 2.8k 1.4× 1.2k 1.4× 540 0.8× 647 1.9× 1.1k 3.6× 81 4.9k
Keith Nehrke 2.4k 1.2× 589 0.7× 519 0.8× 170 0.5× 270 0.9× 97 3.5k
Michel van Weeghel 1.3k 0.7× 634 0.7× 203 0.3× 315 0.9× 231 0.8× 106 2.8k
Norman Moullan 3.2k 1.5× 1.2k 1.4× 708 1.1× 930 2.7× 85 0.3× 35 5.4k
Alexander A. Soukas 1.9k 0.9× 1.2k 1.5× 863 1.3× 794 2.3× 344 1.2× 37 4.1k
Adrienne Mottis 2.0k 1.0× 795 0.9× 412 0.6× 599 1.7× 49 0.2× 18 3.3k
Magdalene K. Montgomery 1.5k 0.7× 1.4k 1.6× 222 0.3× 956 2.7× 183 0.6× 56 3.5k
Keir J. Menzies 2.4k 1.2× 1.5k 1.7× 241 0.4× 772 2.2× 112 0.4× 44 4.4k

Countries citing papers authored by Simon C. Johnson

Since Specialization
Citations

This map shows the geographic impact of Simon C. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon C. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon C. Johnson more than expected).

Fields of papers citing papers by Simon C. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon C. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon C. Johnson. The network helps show where Simon C. Johnson may publish in the future.

Co-authorship network of co-authors of Simon C. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Simon C. Johnson. A scholar is included among the top collaborators of Simon C. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon C. Johnson. Simon C. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kayser, Ernst‐Bernhard, et al.. (2025). Evaluating the efficacy of vatiquinone in preclinical models of Leigh syndrome and GPX4 deficiency. Orphanet Journal of Rare Diseases. 20(1). 65–65. 1 indexed citations
2.
Hanaford, Allison R., Yihan Chen, Michael Mulholland, et al.. (2025). Disruption of adaptive immunity does not attenuate disease in the Ndufs4(-/-) model of Leigh syndrome. PLoS ONE. 20(6). e0324268–e0324268.
3.
Howe, Miranda, Michael Mulholland, Yihan Chen, et al.. (2024). Impact of dietary ketosis on volatile anesthesia toxicity in a model of Leigh syndrome. Pediatric Anesthesia. 34(5). 467–476. 2 indexed citations
4.
Hanaford, Allison R., Yihan Chen, Michael Mulholland, et al.. (2024). Interferon‐gamma contributes to disease progression in the Ndufs4 (−/−) model of Leigh syndrome. Neuropathology and Applied Neurobiology. 50(3). e12977–e12977. 4 indexed citations
5.
Hanaford, Allison R., Michael Mulholland, Margaret M. Sedensky, et al.. (2023). Peripheral macrophages drive CNS disease in the Ndufs4(−/−) model of Leigh syndrome. Brain Pathology. 33(6). e13192–e13192. 8 indexed citations
6.
Mulholland, Michael, John Snell, Miranda Howe, et al.. (2023). Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome. British Journal of Anaesthesia. 131(5). 832–846. 6 indexed citations
7.
González, Brenda, Archana Tare, Seungjin Ryu, et al.. (2022). High-throughput sequencing analysis of nuclear-encoded mitochondrial genes reveals a genetic signature of human longevity. GeroScience. 45(1). 311–330. 5 indexed citations
8.
Hanaford, Allison R. & Simon C. Johnson. (2022). The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence. Orphanet Journal of Rare Diseases. 17(1). 335–335. 30 indexed citations
9.
Cheff, Dorian M., Alysson R. Muotri, Brent R. Stockwell, et al.. (2021). Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities. Orphanet Journal of Rare Diseases. 16(1). 446–446. 14 indexed citations
10.
Kayser, Ernst‐Bernhard, et al.. (2021). Tetraethylammonium chloride reduces anaesthetic-induced neurotoxicity in Caenorhabditis elegans and mice. British Journal of Anaesthesia. 128(1). 77–88. 3 indexed citations
11.
González, Brenda, et al.. (2020). Mitochondrial pathways in human health and aging. Mitochondrion. 54. 72–84. 53 indexed citations
12.
Johnson, Simon C., et al.. (2019). Relevance of experimental paradigms of anesthesia induced neurotoxicity in the mouse. PLoS ONE. 14(3). e0213543–e0213543. 12 indexed citations
13.
Johnson, Simon C., Frank Martinez, Alessandro Bitto, et al.. (2018). mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases. Kidney International. 95(2). 455–466. 40 indexed citations
14.
Johnson, Simon C.. (2018). Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease. Sub-cellular biochemistry. 90. 49–97. 61 indexed citations
15.
Johnson, Simon C., et al.. (2018). Neurotoxicity of anesthetics: Mechanisms and meaning from mouse intervention studies. Neurotoxicology and Teratology. 71. 22–31. 32 indexed citations
16.
Johnson, Simon C., Alessandro Bitto, Anthony S. Castanza, et al.. (2015). Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice. Frontiers in Genetics. 6. 247–247. 71 indexed citations
17.
Carbonell, Alberto, Atsushi Takeda, Noah Fahlgren, et al.. (2014). New Generation of Artificial MicroRNA and Synthetic Trans-Acting Small Interfering RNA Vectors for Efficient Gene Silencing in Arabidopsis. PLANT PHYSIOLOGY. 165(1). 15–29. 107 indexed citations
18.
Johnson, Simon C., Ernst‐Bernhard Kayser, Albert Quintana, et al.. (2013). mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome. Science. 342(6165). 1524–1528. 401 indexed citations
19.
Dai, Dao‐Fu, Simon C. Johnson, Jason J. Villarin, et al.. (2011). Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure. Circulation Research. 108(7). 837–846. 419 indexed citations
20.
Johnson, Simon C.. (2001). Do Mitochondria Regulate Cellular Iron Homeostasis Through Citric Acid and Heme Production? Implications for Cancer and Other Diseases. SSRN Electronic Journal. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026